Randomised clinical trial: Design of the SYNERGY-NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction-associated steatohepatitis and modification of screening strategy to reduce screen failures
However, within the United Kingdom (UK) there is no systematic collection of socioeconomic or patient reported outcome data among HCT recipients
Because of this, it requires caution and monitoring in people with severe kidney impairment
Conversely, the randomized, placebo-controlled, phase 3 study by Elkind-Hirsch et al
Specific gut bacteria play direct roles in GLP-1 secretion
Nausea Vomiting Diarrhea Decreased appetite Upset stomach Constipation Abdominal pain Mounjaro can also sometimes cause serious side effects such as serious, life-threatening allergic reactions (hives, swelling of the tongue or throat, and shortness of breath), inflammation of your pancreas, gallstones, increased risk of certain types of thyroid cancer, vision problems, low blood sugar levels, and kidney injury